{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T01:09:51Z","timestamp":1771463391422,"version":"3.50.1"},"reference-count":36,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T00:00:00Z","timestamp":1730160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Antibiotics"],"abstract":"<jats:p>In children with acute leukemia (AL), the mortality rate from Klebsiella pneumoniae carbapenemase (KPC)-producing K. pneumoniae bloodstream infection (KPC-KpBSI) exceeds 50%, highest when active treatment is delayed. Neutropenic KPC-K. pneumoniae carriers are at high risk of KPC-KpBSI, and preemptive empiric antibiotic treatment (EAT) of febrile neutropenic episodes (FNEs) active against KPC-K. pneumoniae may reduce this mortality. We conducted an 8-year (2014\u20132021) retrospective observational study of 112 febrile neutropenic episodes (FNEs) in 32 children with AL who were KPC-K. pneumoniae carriers: standard EAT for 39 FNEs and active EAT for 73 FNEs (52 ceftazidime\/avibactam (CAZAVI)-based and 21 colistin-based combinations, and 5 CAZAVI monotherapy). Successful outcomes (survival from FNE) were observed in 94%; seven were fatal, with four due to infectious causes. KPC-KpBSIs caused 10\/112 FNEs, 10\/20 g-negative BSIs, and 3 deaths. The mortality rate of KPC-KpBSI was 30%. Active EAT was successful in 97% of the FNEs, compared to 87% with standard EAT. All deaths from KPC-KpBSI occurred in patients who received standard EAT, while none occurred with active EAT. KPC-KpBSI mortality rate with initial inactive treatment was 60%. CAZAVI-based EAT was successful in all FNEs, with a higher success rate without any modification compared to colistin-based EAT, where nephrotoxicity occurred in 14%. Therefore, active EAT, mainly a CAZAVI-based combination, was effective, safe, and associated with low overall and KPC-KpBSI-related mortality.<\/jats:p>","DOI":"10.3390\/antibiotics13111017","type":"journal-article","created":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T08:42:09Z","timestamp":1730191329000},"page":"1017","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-Producing Klebsiella pneumoniae for Febrile Neutropenic Episodes in Colonized Children with Acute Leukemia\u2014An 8-Year Retrospective Observational Study"],"prefix":"10.3390","volume":"13","author":[{"given":"Alessandra","family":"Micozzi","sequence":"first","affiliation":[{"name":"Haematology, Department of Translational and Precision Medicine, Sapienza University of Rome, 00161 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Luise","sequence":"additional","affiliation":[{"name":"Haematology, Azienda Ospedaliera di Rilievo Nazionale Antonio Cardarelli, 80131 Naples, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Lisi","sequence":"additional","affiliation":[{"name":"Haematology, Department of Translational and Precision Medicine, Sapienza University of Rome, 00161 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Moleti","sequence":"additional","affiliation":[{"name":"Department of Haematology, Oncology and Dermatology, Azienda Policlinico Umberto I, 00161 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Santilli","sequence":"additional","affiliation":[{"name":"Department of Diagnostics, Azienda Policlinico Umberto I, 00161 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1105-5256","authenticated-orcid":false,"given":"Giuseppe","family":"Gentile","sequence":"additional","affiliation":[{"name":"Haematology, Department of Translational and Precision Medicine, Sapienza University of Rome, 00161 Rome, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2024,10,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1093\/cid\/cis543","article-title":"Carbapenem-resistant Enterobacteriaceae: An emerging problem in children","volume":"55","author":"Logan","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/cid\/cis036","article-title":"\u2018Silent\u2019 dissemination of Klebsiella pneumoniae isolates bearing K. pneumoniae-carbapenemase in a long-term care facility for children and young adults in Northeast Ohio","volume":"54","author":"Viau","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1097\/INF.0b013e3182804b49","article-title":"Infections caused by carbapenem-resistant Gram-negative pathogens in hospitalized children","volume":"32","author":"Maltezou","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1086\/670997","article-title":"Colonization of high-risk children with carbapenemase-producing Enterobacteriaceae in Greece","volume":"34","author":"Mougkou","year":"2013","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jhin.2013.05.003","article-title":"Emergence of carbapenem-resistant Enterobacteriaceae in a UK paediatric hospital","volume":"84","author":"Drew","year":"2013","journal-title":"J. Hosp. Infect."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/INF.0b013e31828aebc8","article-title":"Antibiotic-resistant Gram-negative bacteremia in pediatric oncology patients, risk factors and outcomes","volume":"32","author":"Haeusler","year":"2013","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1086\/675843","article-title":"Carbapenemase producing enterobacteriaceae (CPE) in the pediatric setting: Results from an 18-month survey","volume":"35","author":"Colombo","year":"2014","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1086\/675593","article-title":"Carbapenem-resistant Enterobacteriaceae in pediatric patients: Epidemiology and risk factors","volume":"35","author":"DeBiasi","year":"2014","journal-title":"Infect. Control Hosp. Epidemiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/INF.0000000000000471","article-title":"Pediatric carbapenem-resistant Enterobacteriaceae in los Angeles, California, a high-prevalence region in the United States","volume":"34","author":"Pannaraj","year":"2015","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3109\/23744235.2015.1087647","article-title":"Incidence of colonization and bloodstream infection with carbapenem-resistant Enterobacteriaceae in children receiving antineoplastic chemotherapy in Italy","volume":"48","author":"Caselli","year":"2016","journal-title":"Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/INF.0000000000000987","article-title":"Clinical characteristics of carbapenem-resistant Klebsiella pneumoniae infections in ill and colonized children in Colombia","volume":"35","author":"Ortiz","year":"2016","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1097\/INF.0000000000001188","article-title":"Carbapenem-resistant Enterobacteriaceae infections in children: An Italian Retrospective Multicenter Study","volume":"35","author":"Montagnani","year":"2016","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11908-015-0510-9","article-title":"Carbapenem-resistant Enterobacteriaceae infections in children","volume":"18","author":"Chiotos","year":"2016","journal-title":"Curr. Infect. Dis. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e161","DOI":"10.1097\/INF.0000000000001499","article-title":"Clinical and bacterial risk factors for mortality in children with carbapenem-resistant Enterobacteriaceae bloodstream infections in India","volume":"36","author":"Nabarro","year":"2017","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"ofy222","DOI":"10.1093\/ofid\/ofy222","article-title":"Increased 30-day mortality associated with carbapenem-resistant Enterobacteriaceae in children","volume":"5","author":"Chiotos","year":"2018","journal-title":"Open Forum Infect. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/INF.0000000000002176","article-title":"A multi-centered case-casecontrol study of factors associated with Klebsiella pneumonia carbapenemase-producing Enterobacteriaceae infections in children and young adults","volume":"38","author":"Logan","year":"2019","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jiph.2018.11.003","article-title":"Epidemiology of carbapenemase-producing Enterobacteriaceae in a pediatric hospital in a country with high endemicity","volume":"12","author":"Castagnola","year":"2019","journal-title":"J. Infect. Public Health"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e02183-19","DOI":"10.1128\/AAC.02183-19","article-title":"Carbapenem-resistant Gram-negative bacterial infections in children","volume":"64","author":"Cercenado","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e01440-17","DOI":"10.1128\/AAC.01440-17","article-title":"Multicenter study of the risk factors for colonization or infection with carbapenem-resistant Enterobacteriaceae in children","volume":"22","author":"Chiotos","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/INF.0000000000000652","article-title":"Antibiotic resistance prevalence in routine bloodstream isolates from children\u2019s hospitals varies substantially from adult surveillance data in Europe","volume":"34","author":"Bielicki","year":"2015","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.jinf.2013.12.006","article-title":"Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients","volume":"68","author":"Mikulska","year":"2014","journal-title":"J. Infect."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Micozzi, A., Gentile, G., Minotti, C., Cartoni, C., Capria, S., Ballar\u00f2, D., Santilli, S., Pacetti, E., Grammatico, S., and Bucaneve, G. (2017). Carbapenem-resistant Klebsiella pneumoniae in high risk hematological patients: Factors favouring spread, risk factors and outcome of carbapenem-resistant Klebsiella pneumoniae bacteremias. BMC Infect. Dis., 17.","DOI":"10.1186\/s12879-017-2297-9"},{"key":"ref_23","first-page":"1079","article-title":"Reduced mortality from KPC-K. pneumoniae bloodstream infection in high-risk patients with hematological malignancies colonized by KPC-K. pneumoniae","volume":"21","author":"Micozzi","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2147\/IDR.S393802","article-title":"Benefits and safety of empiric antibiotic treatment active against KPC-K. pneumoniae in Febrile Neutropenic Patients with Acute Leukemia Who are Colonized with KPC-K. pneumoniae. A 7-Years Retrospective Observational Cohort Study","volume":"16","author":"Micozzi","year":"2023","journal-title":"Infect. Drug Resist."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1097\/MPH.0000000000001814","article-title":"Pediatric febrile neutropenia: Change in etiology of bacteremia, empiric choice of therapy and clinical outcomes","volume":"42","author":"Alali","year":"2020","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.3324\/haematol.2013.091025","article-title":"European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: Summary of the 2011 4th European Conference on Infections in Leukemia","volume":"98","author":"Averbuch","year":"2013","journal-title":"Haematologica"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S1470-2045(20)30725-7","article-title":"8th European Conference on Infections in Leukaemia: 2020 guidelines for the use of antibiotics in paediatric patients with cancer or post-haematopoietic cell transplantation","volume":"22","author":"Lehrnbecher","year":"2021","journal-title":"Lancet Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/cid\/ciz319","article-title":"Inappropriate empiric antibiotic treatment in high-risk neutropenic patients with bacteraemia in the era of multidrug resistance","volume":"70","author":"Gudiol","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/cid\/ciu069","article-title":"Treatment of multidrug-resistant Gramnegative infections in children","volume":"58","author":"Hsu","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1473-3099(17)30228-1","article-title":"Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): A retrospective cohort study","volume":"17","author":"Salamanca","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jiac.2017.12.017","article-title":"The evaluation of safety and efficacy of colistin use in pediatric intensive care unit: Results from two reference hospitals and review of literature","volume":"24","author":"Yazici","year":"2018","journal-title":"J. Infect. Chemother."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijid.2017.03.021","article-title":"Clinical efficacy of ceftazidime\/avibactam versus other active agents for the treatment of bacteraemia due to carbapenemase-producing Enterobacteriaceae in hematologic patients","volume":"59","author":"Loeches","year":"2017","journal-title":"Int. J. Infect. Dis."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1097\/INF.0000000000002344","article-title":"Use of ceftazidime-avibactam for the treatment of extensively drug-resistant or pan drug-resistant Klebsiella pneumoniae in neonates and children <5 years of age","volume":"38","author":"Iosifidis","year":"2019","journal-title":"Pediatr. Infect. Dis. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.2147\/IDR.S209264","article-title":"Optimal management of complicated infections in the pediatric patient: The role and utility of ceftazidime\/avibactam","volume":"13","author":"Bassetti","year":"2020","journal-title":"Infect. Drug Resist."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1093\/cid\/ciw639","article-title":"Ceftazidime-avibactam and carbapenem-resistant enterobacteriaceae: \u201cWe\u2019re Gonna Need a Bigger Boat\u201d","volume":"63","author":"Spellberg","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"516.e1","DOI":"10.1016\/j.cmi.2019.11.011","article-title":"Bloodstream infections caused by KPC producing Klebsiella pneumonia resistant to Ceftazidime\/avibactam: Epidemiology and genomic characterization","volume":"26","author":"Gaibani","year":"2020","journal-title":"Clin. Microbiol. Infect."}],"container-title":["Antibiotics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-6382\/13\/11\/1017\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T16:23:14Z","timestamp":1760113394000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-6382\/13\/11\/1017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,29]]},"references-count":36,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["antibiotics13111017"],"URL":"https:\/\/doi.org\/10.3390\/antibiotics13111017","relation":{},"ISSN":["2079-6382"],"issn-type":[{"value":"2079-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,29]]}}}